Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Beluga Health vs Steady State Health

Beluga Health
Graded #430

Higher grade

vs+0.8999999999999986
Steady State Health
Graded #451

Lower grade

The verdict

Beluga Health takes it — 55.8/100 to 54.9/100, but only just.

Beluga Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Beluga Health is a nationwide white-label telehealth medical group led by Dr. Steady State Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationEven
40
40
Clinical oversightSteady State Health +2
76
78
Labs & monitoringBeluga Health +10
62
52
FulfillmentSteady State Health +1
64
65
Contract termsEven
55
55
Beluga Health · left barSteady State Health · right bar

The numbers

MetricBeluga HealthSteady State Health
WeighScore55.8/10054.9/100
GradeCC
Scorecard rank#430#451
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not published2 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Beluga Health

Graded #430 · C

Strengths

  • Supports GLP-1 care with compounded semaglutide and tirzepatide
  • Board-certified providers and a 50-state medical infrastructure
  • LegitScript certified with SOC 2 and ISO 27001 security
  • Pharmacies follow FDA/USP standards with third-party batch testing
  • Powers many DTC brands as a turnkey telehealth backbone

Where it loses points

  • White-label B2B group, not a direct consumer-facing service
  • Offers compounded, not FDA-approved branded, GLP-1s
  • No public consumer pricing for the GLP-1 offering
  • Cited among nationwide groups tied to FDA telehealth GLP-1 scrutiny
  • Care quality varies by the consumer brand using the platform
Steady State Health

Graded #451 · C

Strengths

  • Prescribes semaglutide or tirzepatide within a perimenopause and menopause hormone-and-metabolic care plan
  • Care delivered by a named women's-health nurse practitioner (Josie Cowburn, DNP, FNP-C)
  • Transparent flat program fee from $139/mo, with a $99/mo standalone GLP-1 support option

Where it loses points

  • Available only to Oregon and Washington residents
  • GLP-1 medication is billed separately by the pharmacy and not included in the program fee
  • Dispensing pharmacy is not publicly named

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard